This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 2 Study to Evaluate the Efficacy and Safet...
Clinical trial

A Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention

Read time: 1 mins
Last updated:30th Aug 2013
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study followed by open-label phase. To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days
Category Value
Study start date 2013-08-30

View full details